10/09/2012 - 11:15am

Beyond 2013, competitive bidding around durable medical equipment supplies could push many pharmacy operations out of the diabetes business altogether.

10/09/2012 - 11:14am

Abusive auditing and unfair reimbursement practices harm community pharmacists’ ability to provide critically needed patient counseling and care to seniors, according to a new survey released Sept. 18 by the National Community Pharmacists Association.

10/09/2012 - 11:13am

The New York City health commissioner’s ban on the sale of big cups of fountain soda drew many an unfavorable accusation that the administration of mayor Michael Bloomberg was trying to turn the city into a nanny state, with NaturalNews.com editor Mike Adams asking, “What’s next? Is Bloomberg gonna pull a Singapore and ban chewing gum too?”

10/09/2012 - 10:25am

Slightly more than one-quarter of shoppers anticipate they will be financially better off a year from now, up from the 22% who held this view one year ago, SymphonyIRI Group reported Tuesday in its second annual EconoLink survey.

10/09/2012 - 6:13am

A meeting with federal officials last week indicates that pharmacists' importance in dispensing animal drugs is growing.

10/08/2012 - 12:31pm

A pharmacy school in Alabama is getting a grant for a program designed to reduce hospitalizations among nursing home residents.

10/08/2012 - 9:15am

European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

10/05/2012 - 11:11am

The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S. representatives for a letter they jointly sent to the Drug Enforcement Administration requesting “clarification, guidance and collaboration,” and suggesting that the federal agency’s efforts in addressing supply chain issues of controlled substances across Florida-based distribution centers and pharmacies may be inadvertently preventing patients from accessing certain prescription drugs for which they have legitimate medical needs and prescriptions.

10/05/2012 - 10:32am

The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.